| Attribute |
Value |
| 52 Week Change |
-0.8395261 |
| Address1 |
677 North Washington Boulevard |
| All Time High |
371.25 |
| All Time Low |
1.3 |
| Ask |
1.92 |
| Ask Size |
2 |
| Average Daily Volume10 Day |
174,290 |
| Average Daily Volume3 Month |
103,031 |
| Average Volume |
103,031 |
| Average Volume10Days |
174,290 |
| Beta |
0.91 |
| Bid |
1.06 |
| Bid Size |
2 |
| Book Value |
4.329 |
| City |
Sarasota |
| Compensation As Of Epoch Date |
1,767,139,200 |
| Country |
United States |
| Crypto Tradeable |
0 |
| Currency |
USD |
| Current Price |
1.4127 |
| Current Ratio |
5.361 |
| Custom Price Alert Confidence |
HIGH |
| Date Short Interest |
1,790,726,400 |
| Day High |
1.4127 |
| Day Low |
1.4127 |
| Display Name |
Silo Pharma |
| Dividend Yield |
0.0 |
| Earnings Timestamp End |
1,755,288,000 |
| Earnings Timestamp Start |
1,754,942,400 |
| Ebitda |
-4,449,849 |
| Ebitda Margins |
0.0 |
| Enterprise To Ebitda |
0.643 |
| Enterprise To Revenue |
-52.901 |
| Enterprise Value |
-2,860,749 |
| Eps Forward |
-0.7 |
| Eps Trailing Twelve Months |
-4.26 |
| Esg Populated |
0 |
| Exchange |
NCM |
| Exchange Data Delayed By |
15 |
| Exchange Timezone Name |
America/New_York |
| Exchange Timezone Short Name |
EDT |
| Fifty Day Average |
2.42834 |
| Fifty Day Average Change |
-1.0156399 |
| Fifty Day Average Change Percent |
-0.41824454 |
| Fifty Two Week Change Percent |
-83.952614 |
| Fifty Two Week High |
10.425 |
| Fifty Two Week High Change |
-9.0123005 |
| Fifty Two Week High Change Percent |
-0.86448926 |
| Fifty Two Week Low |
1.3 |
| Fifty Two Week Low Change |
0.112700105 |
| Fifty Two Week Low Change Percent |
0.08669239 |
| Fifty Two Week Range |
1.3 - 10.425 |
| Financial Currency |
USD |
| First Trade Date Milliseconds |
1,610,116,200,000 |
| Float Shares |
1,573,686 |
| Forward Eps |
-0.7 |
| Forward P E |
-2.018143 |
| Free Cashflow |
-1,642,196 |
| Full Exchange Name |
NasdaqCM |
| Full Time Employees |
3 |
| Fullday Change |
-0.07729995 |
| Fullday Change Percent |
-5.1879163 |
| Fullday Price |
1.4127 |
| Gmt Off Set Milliseconds |
-14,400,000 |
| Gross Margins |
-0.14770001 |
| Gross Profits |
-7,987 |
| Has Pre Post Market Data |
1 |
| Held Percent Insiders |
0.088690005 |
| Held Percent Institutions |
0.08161 |
| Implied Shares Outstanding |
2,053,250 |
| Industry |
Biotechnology |
| Industry Disp |
Biotechnology |
| Industry Key |
biotechnology |
| Is Earnings Date Estimate |
1 |
| Language |
en-US |
| Last Fiscal Year End |
1,767,139,200 |
| Last Split Date |
1,780,444,800 |
| Last Split Factor |
1:15 |
| Long Business Summary |
Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company is developing therapeutics that address underserved conditions, including post-traumatic stress disorder (PTSD), stress-induced anxiety disorders, fibromyalgia, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in formulations. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders. In addition, the company is developing SP-26, a time-release ketamine-loaded implant for fibromyalgia and chronic pain relief. In addition, the company's two preclinical programs comprise SPC-14, an intranasal compound for the treatment of Alzheimer's disease, and SPU-16, a CNS-homing peptide targeting multiple sclerosis (MS). The company's research and development programs are conducted through collaborations with Columbia University, Medspray Pharma BV, and the University of Maryland, Baltimore. The company was formerly known as Uppercut Brands, Inc. and changed its name to Silo Pharma, Inc. in September 2020. Silo Pharma, Inc. was incorporated in 2010 and is based in Sarasota, Florida. |
| Long Name |
Silo Pharma, Inc. |
| Market |
us_market |
| Market Cap |
2,900,626 |
| Market State |
REGULAR |
| Max Age |
86,400 |
| Message Board Id |
finmb_129249050 |
| Most Recent Quarter |
1,782,777,600 |
| Name Change Date |
2,026-10-13 |
| Net Income To Common |
-4,471,914 |
| Next Fiscal Year End |
1,798,675,200 |
| Non Diluted Market Cap |
3,155,850 |
| Open |
1.4127 |
| Operating Cashflow |
-3,340,255 |
| Operating Margins |
-82.50456 |
| Payout Ratio |
0.0 |
| Phone |
718 400 9031 |
| Prev Name |
Uppercut Brands Inc. |
| Previous Close |
1.49 |
| Price Hint |
4 |
| Price To Book |
0.32633403 |
| Price To Sales Trailing12 Months |
53.638813 |
| Profit Margins |
0.0 |
| Quick Ratio |
4.905 |
| Quote Source Name |
Nasdaq Real Time Price |
| Quote Type |
EQUITY |
| Recommendation Key |
none |
| Region |
US |
| Regular Market Change |
-0.07729995 |
| Regular Market Change Percent |
-5.1879163 |
| Regular Market Day High |
1.4127 |
| Regular Market Day Low |
1.4127 |
| Regular Market Day Range |
1.4127 - 1.4127 |
| Regular Market Open |
1.4127 |
| Regular Market Previous Close |
1.49 |
| Regular Market Price |
1.4127 |
| Regular Market Time |
1,791,898,437 |
| Regular Market Volume |
834 |
| Return On Assets |
-0.44245997 |
| Return On Equity |
-0.91232 |
| Revenue Per Share |
0.061 |
| Sand P52 Week Change |
0.17502642 |
| Sector |
Healthcare |
| Sector Disp |
Healthcare |
| Sector Key |
healthcare |
| Shares Outstanding |
2,053,250 |
| Shares Percent Shares Out |
0.0199 |
| Shares Short |
34,870 |
| Shares Short Previous Month Date |
1,788,134,400 |
| Shares Short Prior Month |
33,208 |
| Short Name |
Silo Pharma, Inc. |
| Short Percent Of Float |
0.0218 |
| Short Ratio |
0.67 |
| Source Interval |
15 |
| State |
FL |
| Symbol |
SILO |
| Total Cash |
5,227,242 |
| Total Cash Per Share |
3.291 |
| Total Debt |
0 |
| Total Revenue |
54,077 |
| Tradeable |
0 |
| Trailing Annual Dividend Rate |
0.0 |
| Trailing Annual Dividend Yield |
0.0 |
| Trailing Eps |
-4.26 |
| Trailing Peg Ratio |
None |
| Triggerable |
1 |
| Two Hundred Day Average |
4.86731 |
| Two Hundred Day Average Change |
-3.4546099 |
| Two Hundred Day Average Change Percent |
-0.7097575 |
| Type Disp |
Equity |
| Volume |
834 |
| Website |
https://silopharma.com |
| Zip |
34,236 |